743 related articles for article (PubMed ID: 18167337)
1. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
Yang L; Huang J; Ren X; Gorska AE; Chytil A; Aakre M; Carbone DP; Matrisian LM; Richmond A; Lin PC; Moses HL
Cancer Cell; 2008 Jan; 13(1):23-35. PubMed ID: 18167337
[TBL] [Abstract][Full Text] [Related]
2. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions.
Shaw AK; Pickup MW; Chytil A; Aakre M; Owens P; Moses HL; Novitskiy SV
PLoS One; 2015; 10(1):e0117908. PubMed ID: 25629162
[TBL] [Abstract][Full Text] [Related]
3. Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.
Novitskiy SV; Pickup MW; Chytil A; Polosukhina D; Owens P; Moses HL
J Leukoc Biol; 2012 Sep; 92(3):641-51. PubMed ID: 22685318
[TBL] [Abstract][Full Text] [Related]
4. TGF-β signaling in myeloid cells is required for tumor metastasis.
Pang Y; Gara SK; Achyut BR; Li Z; Yan HH; Day CP; Weiss JM; Trinchieri G; Morris JC; Yang L
Cancer Discov; 2013 Aug; 3(8):936-51. PubMed ID: 23661553
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
7. miR-130a and miR-145 reprogram Gr-1
Ishii H; Vodnala SK; Achyut BR; So JY; Hollander MC; Greten TF; Lal A; Yang L
Nat Commun; 2018 Jul; 9(1):2611. PubMed ID: 29973593
[TBL] [Abstract][Full Text] [Related]
8. Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.
Li Z; Pang Y; Gara SK; Achyut BR; Heger C; Goldsmith PK; Lonning S; Yang L
Int J Cancer; 2012 Dec; 131(11):2584-95. PubMed ID: 22487809
[TBL] [Abstract][Full Text] [Related]
9. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
10. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.
Bierie B; Chung CH; Parker JS; Stover DG; Cheng N; Chytil A; Aakre M; Shyr Y; Moses HL
J Clin Invest; 2009 Jun; 119(6):1571-82. PubMed ID: 19451693
[TBL] [Abstract][Full Text] [Related]
12. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
[TBL] [Abstract][Full Text] [Related]
13. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
[TBL] [Abstract][Full Text] [Related]
15. TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.
Novitskiy SV; Pickup MW; Gorska AE; Owens P; Chytil A; Aakre M; Wu H; Shyr Y; Moses HL
Cancer Discov; 2011 Oct; 1(5):430-41. PubMed ID: 22408746
[TBL] [Abstract][Full Text] [Related]
16. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
17. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
18. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung.
Yan HH; Pickup M; Pang Y; Gorska AE; Li Z; Chytil A; Geng Y; Gray JW; Moses HL; Yang L
Cancer Res; 2010 Aug; 70(15):6139-49. PubMed ID: 20631080
[TBL] [Abstract][Full Text] [Related]
19. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
20. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
